• 21 Hits
  • Search Condition : Filter (MeSH = Endometrial Neoplasms / pathology*)
Species Resource Title
Human and Animal Cells HHUA(RCB0658) Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor.
Human and Animal Cells HOUA-I(RCB0659) MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Human and Animal Cells JHUEM-1(RCB1548) Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter.
Human and Animal Cells HHUA(RCB0658) Establishment and characterization of monoclonal 5-fluorouracil-resistant cell lines derived from human endometrial adenocarcinoma.
Human and Animal Cells HHUA(RCB0658) Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.
Human and Animal Cells HHUA(RCB0658) Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Human and Animal Cells HHUA(RCB0658) Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
Human and Animal Cells Sawano(RCB1152) The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.
Human and Animal Cells HHUA(RCB0658) Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
Human and Animal Cells JHUEM-1(RCB1548) Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.
Human and Animal Cells JHUEM-2(RCB1551) Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer.
Human and Animal Cells HHUA(RCB0658) Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
Human and Animal Cells HHUA(RCB0658) Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
Human and Animal Cells YAC-1(RCB1165) Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
Human and Animal Cells HHUA(RCB0658) , HOUA-I(RCB0659) , Sawano(RCB1152) Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Human and Animal Cells HHUA(RCB0658) Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.
Human and Animal Cells HHUA(RCB0658) Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.
Human and Animal Cells HHUA(RCB0658) , HOUA-I(RCB0659) MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Human and Animal Cells Sawano(RCB1152) , HHUA(RCB0658) , A431(RCB0202) , JHUEM-2(RCB1551) , JHUAS-1(RCB1544) Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Human and Animal Cells p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells.